SuperGen’s PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia

SuperGen’s PIM Kinase Inhibitor, SGI-1776, Effective in Pre-Clinical Models of Acute Lymphoblastic Leukemia

SuperGen’s MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy

SuperGen’s MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy